Found 193 matching trials
Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD) PHASE1 The primary objective is to determine if the opioid properties of ketamine ...
Show More Location
Stanford University
Learn More & Join Trial
Standard Versus High Dose ED-Initiated Buprenorphine Induction PHASE3 This study is a multisite double-blind, double-dummy, randomized clinical t...
Show More Location
Highland Hospital
Learn More & Join Trial
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology PHASE4 This study will assesses the efficacy of buprenorphine/naloxone vs buprenor...
Show More Location
Multiple Locations
Learn More & Join Trial
Endophenotype for Alcohol Misuse in Healthy Minority Populations PHASE4 The purpose of the study is to understand the relationship between what an ...
Show More Location
University of Pennsylvania Treatment Research Center
Learn More & Join Trial
Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine PHASE4 The purpose of this study is to evaluate differences in the pharmacokinetic...
Show More Location
Cardiology Department, Dr. A. Jurasz University Hospital
Learn More & Join Trial
Buprenorphine as a Treatment in Opiate Dependent Pain Patients PHASE4 This study is designed to determine if different doses of buprenorphine (ei...
Show More Location
Erie County Medical Center
Learn More & Join Trial
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence NA Opioid medications are commonly used for pain relief. When given over time,...
Show More Location
Stanford University
Learn More & Join Trial
ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults PHASE4 This was a study of the effects of VIVITROL® on alcohol cue-induced craving...
Show More Learn More & Join Trial
Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101) PHASE1 PF614 is an oxycodone prodrug that is designed for extended-release of oxyc...
Show More Location
PRA Health Sciences - Early Development Services
Learn More & Join Trial
Sweet Preference and Alcohol Craving PHASE2 Purpose: The proposed 2-year investigation will be the first double-blind, ...
Show More Location
University of North Carolina - Chapel Hill
Learn More & Join Trial